0001209191-17-017880.txt : 20170303 0001209191-17-017880.hdr.sgml : 20170303 20170303174927 ACCESSION NUMBER: 0001209191-17-017880 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170301 FILED AS OF DATE: 20170303 DATE AS OF CHANGE: 20170303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cancelmi Daniel J CENTRAL INDEX KEY: 0001396106 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 17665593 MAIL ADDRESS: STREET 1: 13737 NOEL ROAD STREET 2: SUITE 100 CITY: DALLAS STATE: TX ZIP: 75240 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-01 0 0000070318 TENET HEALTHCARE CORP THC 0001396106 Cancelmi Daniel J 1445 ROSS AVENUE SUITE 1400 DALLAS TX 75202 0 1 0 0 Chief Financial Officer 2017 March Restricted Stock Units 2017-03-01 4 A 0 40373 0.00 A Common Stock 40373 40373 D 2017 March Performance Stock Options (Right to Buy) 18.99 2017-03-01 4 A 0 89976 0.00 A 2027-03-01 Common Stock 89976 89976 D These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. These performance-based stock options vest on the third anniversary of the date of grant, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $23.74 per share for any 20 consecutive trading days during the three-year period following the date of grant. Anthony L. Shoemaker, as Attorney-in-Fact for Daniel J. Cancelmi 2017-03-03